PortfoliosLab logoPortfoliosLab logo
CZMGX vs. LIVIX
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

CZMGX vs. LIVIX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Multi-Manager Growth Strategies Fund (CZMGX) and BlackRock LifePath Index 2055 Fund (LIVIX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, CZMGX achieves a 9.32% return, which is significantly lower than LIVIX's 12.57% return.


CZMGX

1D
0.09%
1M
3.65%
YTD
9.32%
6M
8.24%
1Y
24.55%
3Y*
24.62%
5Y*
13.66%
10Y*

LIVIX

1D
0.41%
1M
2.10%
YTD
12.57%
6M
13.11%
1Y
29.28%
3Y*
19.89%
5Y*
10.23%
10Y*
11.94%
*Multi-year figures are annualized to reflect compound growth (CAGR)

CZMGX vs. LIVIX - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
CZMGX
Multi-Manager Growth Strategies Fund
9.32%15.18%34.55%41.78%-29.41%19.80%33.39%33.59%-12.36%25.10%
LIVIX
BlackRock LifePath Index 2055 Fund
12.57%21.57%13.60%21.62%-18.38%18.75%14.99%26.76%-7.83%18.53%

Correlation

The correlation between CZMGX and LIVIX is 0.86, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.86

Correlation (3Y)
Calculated over the trailing 3-year period

0.85

Correlation (5Y)
Calculated over the trailing 5-year period

0.89

Correlation (All Time)
Calculated using the full available price history since Feb 2, 2017

0.88

The correlation between CZMGX and LIVIX has been stable across timeframes, ranging from 0.85 to 0.89 - a consistent structural relationship.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

CZMGX vs. LIVIX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CZMGX
CZMGX Risk / Return Rank: 2525
Overall Rank
CZMGX Sharpe Ratio Rank: 3131
Sharpe Ratio Rank
CZMGX Sortino Ratio Rank: 2828
Sortino Ratio Rank
CZMGX Omega Ratio Rank: 2929
Omega Ratio Rank
CZMGX Calmar Ratio Rank: 1818
Calmar Ratio Rank
CZMGX Martin Ratio Rank: 1919
Martin Ratio Rank

LIVIX
LIVIX Risk / Return Rank: 6767
Overall Rank
LIVIX Sharpe Ratio Rank: 6767
Sharpe Ratio Rank
LIVIX Sortino Ratio Rank: 6464
Sortino Ratio Rank
LIVIX Omega Ratio Rank: 6262
Omega Ratio Rank
LIVIX Calmar Ratio Rank: 6969
Calmar Ratio Rank
LIVIX Martin Ratio Rank: 7676
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CZMGX vs. LIVIX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Multi-Manager Growth Strategies Fund (CZMGX) and BlackRock LifePath Index 2055 Fund (LIVIX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


CZMGXLIVIXDifference
Sharpe ratioReturn per unit of total volatility

-0.81

Sortino ratioReturn per unit of downside risk

-1.13

Omega ratioGain probability vs. loss probability

1.27

1.42

-0.15

Calmar ratioReturn relative to maximum drawdown

1.44

3.09

-1.65

Martin ratioReturn relative to average drawdown

4.68

13.69

-9.01

CZMGX vs. LIVIX - Sharpe Ratio Comparison

The current CZMGX Sharpe Ratio is 1.51, which is lower than the LIVIX Sharpe Ratio of 2.32. The chart below compares the historical Sharpe Ratios of CZMGX and LIVIX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


CZMGXLIVIXDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.51

2.32

-0.81

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.64

0.65

-0.01

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.72

Sharpe Ratio (All Time)

Calculated using the full available price history

0.73

0.64

+0.09

Drawdowns

CZMGX vs. LIVIX - Drawdown Comparison

The maximum CZMGX drawdown since its inception was -35.23%, roughly equal to the maximum LIVIX drawdown of -34.44%. Use the drawdown chart below to compare losses from any high point for CZMGX and LIVIX.


Loading charts...

Drawdown Indicators


CZMGXLIVIXDifference

Max Drawdown

Largest peak-to-trough decline

-35.23%

-34.44%

-0.79%

Max Drawdown (1Y)

Largest decline over 1 year

-16.55%

-9.44%

-7.11%

Max Drawdown (3Y)

Largest decline over 3 years

-22.71%

-17.39%

-5.32%

Max Drawdown (5Y)

Largest decline over 5 years

-35.23%

-26.45%

-8.78%

Max Drawdown (10Y)

Largest decline over 10 years

-34.44%

Current Drawdown

Current decline from peak

-0.86%

-0.46%

-0.40%

Average Drawdown

Average peak-to-trough decline

-7.58%

-4.52%

-3.06%

Ulcer Index

Depth and duration of drawdowns from previous peaks

5.07%

2.13%

+2.94%

Volatility

CZMGX vs. LIVIX - Volatility Comparison

The current volatility for Multi-Manager Growth Strategies Fund (CZMGX) is 3.58%, while BlackRock LifePath Index 2055 Fund (LIVIX) has a volatility of 3.84%. This indicates that CZMGX experiences smaller price fluctuations and is considered to be less risky than LIVIX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


CZMGXLIVIXDifference

Volatility (1M)

Calculated over the trailing 1-month period

3.58%

3.84%

-0.26%

Volatility (6M)

Calculated over the trailing 6-month period

11.82%

10.10%

+1.72%

Volatility (1Y)

Calculated over the trailing 1-year period

15.71%

12.57%

+3.14%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

21.52%

15.84%

+5.68%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

21.83%

16.71%

+5.12%

CZMGX vs. LIVIX - Expense Ratio Comparison

CZMGX has a 0.74% expense ratio, which is higher than LIVIX's 0.10% expense ratio.


Dividends

CZMGX vs. LIVIX - Dividend Comparison

CZMGX has not paid dividends to shareholders, while LIVIX's dividend yield for the trailing twelve months is around 2.20%.


PositionTTM20252024202320222021202020192018201720162015
CZMGX
Multi-Manager Growth Strategies Fund
0.00%11.02%10.86%5.59%10.39%15.19%5.04%5.53%6.87%4.66%0.00%0.00%
LIVIX
BlackRock LifePath Index 2055 Fund
2.20%2.48%0.01%2.04%1.96%2.04%1.56%2.95%2.35%2.27%1.54%2.88%

Frequently Asked Questions


CZMGX and LIVIX have a correlation of 0.86, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

LIVIX has higher volatility (3.84%) compared to CZMGX (3.58%). In terms of maximum drawdown, CZMGX dropped -35.23% vs LIVIX's -34.44%.

LIVIX currently has the higher Sharpe Ratio (2.32 vs 1.51), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for CZMGX and LIVIX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer